Cancer Genetics, Inc. Launches Digital Platform to Enable Collaboration with Community Hospitals and Laboratories

By Italia on January 20 2015

RUTHERFORD, N.J., January 20, 2014 (GlobeNewswire) — Cancer Genetics, Inc., (Nasdaq: CGIX) (“CGI” or “the company”), an emerging leader in DNA-based cancer diagnostics, announced today the launch of their ExpandDxTM collaborative testing program. CGI’s ExpandDx program, which utilizes VENTANA digital pathology technology from Roche, allows community-based hospitals and pathology labs to partner with CGI through remote consultations, […]

Continue Reading

Cancer Genetics, Inc. Receives Approval to Provide Oncology Testing for Patients in California

By Italia on January 5 2015

>> Approval Allows CGI to Access Largest National Market for Oncology Testing Services RUTHERFORD, N.J., January 05, 2015 (Globe Newswire) —Cancer Genetics, Inc. (Nasdaq: CGIX, “CGI” or “the company”), an emerging leader in DNA-based cancer diagnostics, announced today that its CLIA-certified, CAP-accredited reference laboratory has received licensure from the California Department of Health. The California Clinical Laboratory License […]

Continue Reading